Bibi I Hasnain, MD | |
201 Bjc Saint Peters Dr Ste 200, Saint Peters, MO 63376-3386 | |
(636) 916-9615 | |
Not Available |
Full Name | Bibi I Hasnain |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 30 Years |
Location | 201 Bjc Saint Peters Dr Ste 200, Saint Peters, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467562983 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Barnes-jewish St Peters Hospital | Saint peters, MO | Hospital |
Progress West Hospital | O fallon, MO | Hospital |
Christian Hospital Northeast | Saint louis, MO | Hospital |
Missouri Baptist Medical Center | Town and country, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Physician Groups Lc | 3072421254 | 409 |
News Archive
A new, noninvasive, and low-cost method for the early detection and monitoring of osteoarthritis (arthritis caused by wear and tear) may be on its way, thanks to research by UC Santa Barbara scientists from the Department of Chemical Engineering and the Department of Materials.
Vejthani Hospital Bangkok offers a High Tibial Osteotomy Surgery for osteoarthritis at TJR Center. The procedure prolongs the life of a damaged knee, helps relieve pain in the knee and delays the need for a total knee replacement.
Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
› Verified 1 days ago
Entity Name | Physician Groups Lc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285664268 PECOS PAC ID: 3072421254 Enrollment ID: O20040220001157 |
News Archive
A new, noninvasive, and low-cost method for the early detection and monitoring of osteoarthritis (arthritis caused by wear and tear) may be on its way, thanks to research by UC Santa Barbara scientists from the Department of Chemical Engineering and the Department of Materials.
Vejthani Hospital Bangkok offers a High Tibial Osteotomy Surgery for osteoarthritis at TJR Center. The procedure prolongs the life of a damaged knee, helps relieve pain in the knee and delays the need for a total knee replacement.
Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Bibi I Hasnain, MD 201 Bjc Saint Peters Dr Ste 200, Saint Peters, MO 63376-3386 Ph: (636) 916-9615 | Bibi I Hasnain, MD 201 Bjc Saint Peters Dr Ste 200, Saint Peters, MO 63376-3386 Ph: (636) 916-9615 |
News Archive
A new, noninvasive, and low-cost method for the early detection and monitoring of osteoarthritis (arthritis caused by wear and tear) may be on its way, thanks to research by UC Santa Barbara scientists from the Department of Chemical Engineering and the Department of Materials.
Vejthani Hospital Bangkok offers a High Tibial Osteotomy Surgery for osteoarthritis at TJR Center. The procedure prolongs the life of a damaged knee, helps relieve pain in the knee and delays the need for a total knee replacement.
Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.
Ferrer, a privately-held Spanish pharmaceutical company, today announces that the first patient has been recruited into a second phase III trial of Ozenoxacin, formulated as a topical treatment for infectious dermatological conditions in adult and paediatric patients with impetigo. The study is scheduled to complete in Q1, 2015.
› Verified 1 days ago
Furqan F Raja, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Circle, Suite 405, Saint Peters, MO 63376 Phone: 636-720-0310 Fax: 636-720-0311 | |
Dr. Pierre Moeser, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 70 Jungermann Cir, Ste 300, Saint Peters, MO 63376 Phone: 636-916-9020 Fax: 636-916-9021 | |
Dr. Ron Javdan, M.D. Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 6 Jungermann Cir, Suite 203, Saint Peters, MO 63376 Phone: 636-928-1822 Fax: 636-441-7033 | |
Dr. Lawrence Osei, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Dept Anesthesiology, Saint Peters, MO 63376 Phone: 800-862-9980 Fax: 314-362-1185 | |
Dr. Anna Roshal, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 150 Entrance Way, Saint Peters, MO 63376 Phone: 636-916-9920 Fax: 636-916-9176 | |
Dr. Sandeep Hindupur, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr Ste 100, Saint Peters, MO 63376 Phone: 636-916-7272 | |
April Thebeau, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Hospital Dr, Saint Peters, MO 63376 Phone: 314-317-0600 Fax: 314-317-0606 |